Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
ARTL

Overview Financials Analysis Smart Money

Artelo Biosciences, Inc.

ARTL · NASDAQ

Analyze with AI

Filings1

Total reported value$26.6K

Manager	Shares	Value	Change
KEYSTONE WEALTH PARTNERS	15K	$26.6K	+50.0%

SymbolARTL

Market Cap$3.6M

IPO Date2019-06-21

CEOGregory D. Gorgas

Employees6

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Sable Offshore Corp.

SOC

$8.83

+67.14%

Athira Pharma, Inc.

ATHA

$6.90

+66.77%

urban-gro, Inc.

UGRO

$0.46

+55.41%

Paranovus Entertainment Technology Ltd.

PAVS

$2.86

+43.47%

FuelCell Energy, Inc.

FCEL

$10.65

+34.81%

Peers

GT Biopharma, Inc.

GTBP · NASDAQ

$0.7108

+1.54%

Protagenic Therapeutics, Inc.

PTIX · NASDAQ

$1.28

-6.94%

Carisma Therapeutics, Inc.

CARM · NASDAQ

$0.05

+2.04%

Salarius Pharmaceuticals, Inc.

SLRX · NASDAQ

$0.6704

+2.66%

Psyence Biomedical Ltd.

PBM · NASDAQ

$1.50

+1.35%

Revelation Biosciences, Inc.

REVB · NASDAQ

$0.9317

+0.13%

Lipella Pharmaceuticals Inc.

LIPO · NASDAQ

$0.21

-8.74%

SciSparc Ltd.

SPRC · NASDAQ

$1.59

+1.92%

Silexion Therapeutics Ltd.

SLXN · NASDAQ

$2.50

-2.53%

Windtree Therapeutics, Inc.

WINT · NASDAQ

$0.04

+5.26%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.